In addition to the metabolic disorder tests required in SDCL 34-24-18, a designated laboratory shall screen any infant born in this state for the following newborn screening disorders:

1. (1) Hemoglobinopathies;
2. (2) Biotinidase deficiency;
3. (3) Classical congenital adrenal hyperplasia;
4. (4) Fatty acid oxidation disorders;
5. (5) Amino acid disorders;
6. (6) Organic acid disorders;
7. (7) Cystic fibrosis;
8. (8) Severe combined immunodeficiency disorder;
9. (9) Spinal muscular atrophy;
10. (10) Glycogen storage disease type II or Pompe disease; and

11. (11) X-linked adrenoleukodystrophy (X-ALD).

    Each physician, nurse practitioner, physician assistant, certified nurse midwife, or certified professional midwife providing childbirth services shall perform a newborn hearing screening on any infant the provider or midwife delivers in this state.

Source: 31 SDR 164, effective May 9, 2005; 33 SDR 180, effective May 7, 2007; 42 SDR 14, effective August 10, 2015 ; 47 SDR 137, effective June 28, 2021; 49 SDR 16, effective September 1, 2022; 50 SDR 139, effective June 2, 2024 .

General Authority: SDCL 34-24-25 .

Law Implemented: SDCL 34-24-22 .

Prior versions effective: 2022-09-01, 2021-06-28, 2015-08-10, 2007-05-07.